Agrippal

BIOLOGICAL6 trials

Sponsors

Crucell Holland BV, University of Surrey, Korea University Guro Hospital, SK Bioscience Co., Ltd., SK Chemicals Co., Ltd.

Conditions

Chronic Kidney DiseaseEnd Stage Renal FailureHealthyInfluenzaPrevention of Influenza

Phase 1

Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers

CompletedNCT03826719

SK Chemicals Co., Ltd.Influenza

Start: 2014-02-17End: 2014-03-28Updated: 2019-02-01

Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy Adults

CompletedNCT03893669

SK Chemicals Co., Ltd.Prevention of Influenza

Start: 2012-09-30End: 2012-11-30Updated: 2019-03-28

Phase 3

Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children

CompletedNCT01310400

Crucell Holland BVInfluenza

Start: 2009-10-31End: 2010-01-31Updated: 2014-02-06

Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months

CompletedNCT03704740

SK Bioscience Co., Ltd.Influenza

Start: 2018-10-25End: 2019-07-12Updated: 2022-05-11

Phase 4

Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis

CompletedNCT02686398

Korea University Guro HospitalChronic Kidney Disease, End Stage Renal Failure, Influenza

Start: 2013-10-31End: 2014-11-30Updated: 2016-02-19

Unknown Phase

Training Study to Characterize Biomarkers to Flu Vaccines

CompletedNCT01771367

University of SurreyHealthy

Start: 2013-01-31End: 2013-11-30Updated: 2015-02-16

Related Papers

Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium.

2019-12-3029 citations

Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review.

2016-08-0430 citations